Julie Smith
Director · 2 filings · Latest: Jun 3, 2026
EXELIXIS, INC.
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
EXEL | Julie Smith | Director | May 27, 2026 | Grant/Award | $0.00 | 8,367 | — | 28,957 |